Bupropion & Sexuality: Managing Antidepressant-Induced Sexual Dysfunction (AISD) in 2025 Why Bupropion Matters in Treating Antidepressant Sexual Side Effects Sexual dysfunction is one of the most common and underreported side effects of antidepressant therapy. Among individuals taking selective serotonin reuptake inhibitors (SSRIs), rates of sexual dysfunction range from 30% to as high as 70%, depending…

Sildenafil 100 mg: Psychophysiological Profile & Role in SSRI-Induced Sexual Dysfunction Generic Viagra (sildenafil 100 mg) has become a cornerstone in the management of SSRI-induced sexual dysfunction (SSRI-SD), a common and distressing side effect of modern antidepressant therapy. This 2025 review synthesizes the latest clinical evidence, pharmacology, and telehealth access pathways for patients and clinicians…

Bupropion vs Varenicline vs Cytisine: Which Works Best for Quitting? Mechanistic Differences: How Zyban, Chantix & Cytisine Work Pharmacologic treatments for tobacco dependence target the brain’s cholinergic and dopaminergic systems. Although all three agents—Bupropion (Zyban®), Varenicline (Chantix®), and Cytisine—reduce nicotine cravings and withdrawal symptoms, their mechanisms differ significantly. Bupropion is a norepinephrine - dopamine reuptake…

Bupropion for Smoking Cessation: Updated Cochrane Evidence & Clinical Practice (2025) Why Consider Bupropion Instead of Cold Turkey? Most people who try to quit smoking do so without medications like Bupropion commonly known as “going cold turkey.” Unfortunately, this approach has low success rates. Only about 3–5% of unaided quit attempts lead to long-term abstinence…

Bupropion + Naltrexone (Contrave): Synergistic Effects & Safety POMC Feedback Loop & β-Endorphin Blockade Contrave® is a fixed-dose combination of naltrexone and bupropion approved for chronic weight management. Its mechanism targets both the hypothalamic hunger pathways and the mesolimbic reward system, resulting in dual action on appetite and cravings. The key to its synergistic effect…

Bupropion for Weight Loss: Efficacy, Mechanisms & Clinical Evidence Why Consider Bupropion for Weight Management? Weight gain is a common and often distressing side effect of many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs). Studies suggest that up to 25–30 % of SSRI users experience clinically significant weight gain within 6 to 12 months of…

Bupropion Formulations & Dosing: IR vs. SR vs. XL – Which to Choose? By Oliver Freudenreich, MD  | Medically reviewed by Graham Thornicroft, MBBS, PhD, FRCPsych  | Last updated:7 May 2025 Bupropion Release-Profile Basics: IR vs SR vs XL Bupropion is available in three primary formulations - immediate-release (IR), sustained-release (SR), and extended-release (XL). Each formulation has a distinct…

Bupropion Mechanism of Action Why Bupropion Targets Dopamine & Norepinephrine in Depression Major depressive disorder is associated with dysregulation of monoaminergic systems, including dopamine and norepinephrine. These neurotransmitters play central roles in reward processing, energy, motivation, and executive function. Bupropion directly affects these systems, making it unique among antidepressants. Unlike serotonergic agents, Bupropion offers symptom…

Bupropion (IR/SR/XL): Complete Pharmacology & Evidence-Based Guide [2025] Overview & History Bupropion was initially approved by the FDA in 1985 for treating major depressive disorder (MDD) under the brand name Wellbutrin®. Shortly after its launch, it was temporarily withdrawn from the market in 1986 due to seizure risk concerns identified at higher doses. Following adjustments…

Abilify Mechanism of Action: Dopamine-Serotonin Modulation Explained Abilify Drug Class and Pharmacodynamic Profile Abilify (aripiprazole) is classified as an atypical antipsychotic and is often described as a dopamine-serotonin system stabilizerStahl 2021. The abilify drug class is distinguished by its unique pharmacodynamic profile, which includes partial agonism at dopamine D2 and D3 receptors, as well as…